Bavituximab With Radiation and Temozolomide for Patients With Newly Diagnosed Glioblastoma

Location: Boston, MA

Massachusetts General Hospital and Dana Farber Cancer Institute

Learn More

Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma

Location: Dallas, TX

University of Texas Southwestern Medical Center

Learn More




Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid Malignancies

Location: Houston, TX

University of Texas MD Anderson Cancer Center

Learn More

Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment (IMPALA)

Recruitment Closed

Learn More